The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Decitabine Sales Market Report 2024

Global Decitabine Sales Market Report 2024

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1623884

No of Pages : 147

Synopsis
Decitabine is also known as 5 - nitrogen hetero - 2 '- DNA cytosine nucleoside, 5 - n - 2' - deoxy cytidine acid, is a kind of natural 2 '- deoxy cytidine acid adenosine analogues, by inhibiting the DNA methyltransferase, reduce DNA methylation, thus inhibiting tumor cell proliferation, and prevent the occurrence of drug resistance, for the strongest known DNA methylation specific inhibitor, belongs to the S phase of cell cycle specific drugs, is suitable for the treatment of myelodysplastic syndrome (MDS).

Market Analysis and Insights: Global Decitabine Market
The global Decitabine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Decitabine Scope and Market Size
The global Decitabine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Decitabine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms

Segment by Application
Primary MDS
Secondary MDS

The Decitabine market is analysed and market size information is provided by regions (countries). Segment by Application, the Decitabine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy's Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
Index
1 Decitabine Market Overview
1.1 Decitabine Product Scope
1.2 Decitabine Segment by Type
1.2.1 Global Decitabine Sales by Type (2016 & 2021 & 2027)
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Decitabine Segment by Application
1.3.1 Global Decitabine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Decitabine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Decitabine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Decitabine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Decitabine Price Trends (2016-2027)

2 Decitabine Estimates and Forecasts by Region
2.1 Global Decitabine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Decitabine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Decitabine Sales Market Share by Region (2016-2021)
2.2.2 Global Decitabine Revenue Market Share by Region (2016-2021)
2.3 Global Decitabine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Decitabine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Decitabine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Decitabine Estimates and Projections (2016-2027)
2.4.2 Europe Decitabine Estimates and Projections (2016-2027)
2.4.3 China Decitabine Estimates and Projections (2016-2027)
2.4.4 Japan Decitabine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Decitabine Estimates and Projections (2016-2027)
2.4.6 India Decitabine Estimates and Projections (2016-2027)
3 Global Decitabine Competition Landscape by Players
3.1 Global Top Decitabine Players by Sales (2016-2021)
3.2 Global Top Decitabine Players by Revenue (2016-2021)
3.3 Global Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decitabine as of 2020)
3.4 Global Decitabine Average Price by Company (2016-2021)
3.5 Manufacturers Decitabine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Decitabine Market Size by Type
4.1 Global Decitabine Historic Market Review by Type (2016-2021)
4.1.1 Global Decitabine Sales Market Share by Type (2016-2021)
4.1.2 Global Decitabine Revenue Market Share by Type (2016-2021)
4.1.3 Global Decitabine Price by Type (2016-2021)
4.2 Global Decitabine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Decitabine Sales Forecast by Type (2022-2027)
4.2.2 Global Decitabine Revenue Forecast by Type (2022-2027)
4.2.3 Global Decitabine Price Forecast by Type (2022-2027)
5 Global Decitabine Market Size by Application
5.1 Global Decitabine Historic Market Review by Application (2016-2021)
5.1.1 Global Decitabine Sales Market Share by Application (2016-2021)
5.1.2 Global Decitabine Revenue Market Share by Application (2016-2021)
5.1.3 Global Decitabine Price by Application (2016-2021)
5.2 Global Decitabine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Decitabine Sales Forecast by Application (2022-2027)
5.2.2 Global Decitabine Revenue Forecast by Application (2022-2027)
5.2.3 Global Decitabine Price Forecast by Application (2022-2027)

6 North America Decitabine Market Facts & Figures
6.1 North America Decitabine Sales by Company
6.1.1 North America Decitabine Sales by Company (2016-2021)
6.1.2 North America Decitabine Revenue by Company (2016-2021)
6.2 North America Decitabine Sales Breakdown by Type
6.2.1 North America Decitabine Sales Breakdown by Type (2016-2021)
6.2.2 North America Decitabine Sales Breakdown by Type (2022-2027)
6.3 North America Decitabine Sales Breakdown by Application
6.3.1 North America Decitabine Sales Breakdown by Application (2016-2021)
6.3.2 North America Decitabine Sales Breakdown by Application (2022-2027)

7 Europe Decitabine Market Facts & Figures
7.1 Europe Decitabine Sales by Company
7.1.1 Europe Decitabine Sales by Company (2016-2021)
7.1.2 Europe Decitabine Revenue by Company (2016-2021)
7.2 Europe Decitabine Sales Breakdown by Type
7.2.1 Europe Decitabine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Decitabine Sales Breakdown by Type (2022-2027)
7.3 Europe Decitabine Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Decitabine Market Facts & Figures
8.1 China Decitabine Sales by Company
8.1.1 China Decitabine Sales by Company (2016-2021)
8.1.2 China Decitabine Revenue by Company (2016-2021)
8.2 China Decitabine Sales Breakdown by Type
8.2.1 China Decitabine Sales Breakdown by Type (2016-2021)
8.2.2 China Decitabine Sales Breakdown by Type (2022-2027)
8.3 China Decitabine Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Decitabine Market Facts & Figures
9.1 Japan Decitabine Sales by Company
9.1.1 Japan Decitabine Sales by Company (2016-2021)
9.1.2 Japan Decitabine Revenue by Company (2016-2021)
9.2 Japan Decitabine Sales Breakdown by Type
9.2.1 Japan Decitabine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Decitabine Sales Breakdown by Type (2022-2027)
9.3 Japan Decitabine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Decitabine Market Facts & Figures
10.1 Southeast Asia Decitabine Sales by Company
10.1.1 Southeast Asia Decitabine Sales by Company (2016-2021)
10.1.2 Southeast Asia Decitabine Revenue by Company (2016-2021)
10.2 Southeast Asia Decitabine Sales Breakdown by Type
10.2.1 Southeast Asia Decitabine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Decitabine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Decitabine Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Decitabine Market Facts & Figures
11.1 India Decitabine Sales by Company
11.1.1 India Decitabine Sales by Company (2016-2021)
11.1.2 India Decitabine Revenue by Company (2016-2021)
11.2 India Decitabine Sales Breakdown by Type
11.2.1 India Decitabine Sales Breakdown by Type (2016-2021)
11.2.2 India Decitabine Sales Breakdown by Type (2022-2027)
11.3 India Decitabine Sales Breakdown by Application
11.3.1 India Decitabine Sales Breakdown by Application (2016-2021)
11.3.2 India Decitabine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Decitabine Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Decitabine Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Corporation Information
12.2.2 Eli Lilly and Company Business Overview
12.2.3 Eli Lilly and Company Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly and Company Decitabine Products Offered
12.2.5 Eli Lilly and Company Recent Development
12.3 Pharmachemie B.V.
12.3.1 Pharmachemie B.V. Corporation Information
12.3.2 Pharmachemie B.V. Business Overview
12.3.3 Pharmachemie B.V. Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pharmachemie B.V. Decitabine Products Offered
12.3.5 Pharmachemie B.V. Recent Development
12.4 Otsuka Pharmaceutical
12.4.1 Otsuka Pharmaceutical Corporation Information
12.4.2 Otsuka Pharmaceutical Business Overview
12.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Otsuka Pharmaceutical Decitabine Products Offered
12.4.5 Otsuka Pharmaceutical Recent Development
12.5 Sandoz
12.5.1 Sandoz Corporation Information
12.5.2 Sandoz Business Overview
12.5.3 Sandoz Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sandoz Decitabine Products Offered
12.5.5 Sandoz Recent Development
12.6 Dr Reddy's Laboratories
12.6.1 Dr Reddy's Laboratories Corporation Information
12.6.2 Dr Reddy's Laboratories Business Overview
12.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dr Reddy's Laboratories Decitabine Products Offered
12.6.5 Dr Reddy's Laboratories Recent Development
12.7 Accord Healthcare
12.7.1 Accord Healthcare Corporation Information
12.7.2 Accord Healthcare Business Overview
12.7.3 Accord Healthcare Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Accord Healthcare Decitabine Products Offered
12.7.5 Accord Healthcare Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Corporation Information
12.8.2 Sun Pharmaceutical Business Overview
12.8.3 Sun Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Decitabine Products Offered
12.8.5 Sun Pharmaceutical Recent Development
12.9 Cipla
12.9.1 Cipla Corporation Information
12.9.2 Cipla Business Overview
12.9.3 Cipla Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Cipla Decitabine Products Offered
12.9.5 Cipla Recent Development
12.10 Lupin
12.10.1 Lupin Corporation Information
12.10.2 Lupin Business Overview
12.10.3 Lupin Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lupin Decitabine Products Offered
12.10.5 Lupin Recent Development
12.11 Shandong Xinshidai Pharmaceutical
12.11.1 Shandong Xinshidai Pharmaceutical Corporation Information
12.11.2 Shandong Xinshidai Pharmaceutical Business Overview
12.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shandong Xinshidai Pharmaceutical Decitabine Products Offered
12.11.5 Shandong Xinshidai Pharmaceutical Recent Development
12.12 Hangzhou Zhongmei Huadong Pharmaceutical
12.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
12.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
12.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Products Offered
12.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
12.13 ZHENGDA Tianqing Pharmaceutical Group
12.13.1 ZHENGDA Tianqing Pharmaceutical Group Corporation Information
12.13.2 ZHENGDA Tianqing Pharmaceutical Group Business Overview
12.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Products Offered
12.13.5 ZHENGDA Tianqing Pharmaceutical Group Recent Development
12.14 Jiangsu Aosaikang Pharmaceutical
12.14.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
12.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
12.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Products Offered
12.14.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12.15 Jiangsu Haosen Pharmaceutical Group
12.15.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
12.15.2 Jiangsu Haosen Pharmaceutical Group Business Overview
12.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Products Offered
12.15.5 Jiangsu Haosen Pharmaceutical Group Recent Development
12.16 Lianyungang Jierui Pharmaceutical
12.16.1 Lianyungang Jierui Pharmaceutical Corporation Information
12.16.2 Lianyungang Jierui Pharmaceutical Business Overview
12.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Lianyungang Jierui Pharmaceutical Decitabine Products Offered
12.16.5 Lianyungang Jierui Pharmaceutical Recent Development
12.17 Qilu Pharmaceutical Hainan
12.17.1 Qilu Pharmaceutical Hainan Corporation Information
12.17.2 Qilu Pharmaceutical Hainan Business Overview
12.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Qilu Pharmaceutical Hainan Decitabine Products Offered
12.17.5 Qilu Pharmaceutical Hainan Recent Development
12.18 Lianyungang Runzhong Pharmaceutical
12.18.1 Lianyungang Runzhong Pharmaceutical Corporation Information
12.18.2 Lianyungang Runzhong Pharmaceutical Business Overview
12.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Products Offered
12.18.5 Lianyungang Runzhong Pharmaceutical Recent Development

13 Decitabine Manufacturing Cost Analysis
13.1 Decitabine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Decitabine
13.4 Decitabine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Decitabine Distributors List
14.3 Decitabine Customers

15 Market Dynamics
15.1 Decitabine Market Trends
15.2 Decitabine Drivers
15.3 Decitabine Market Challenges
15.4 Decitabine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Decitabine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Decitabine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Decitabine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Decitabine Sales (K Units) by Region (2016-2021)
Table 5. Global Decitabine Sales Market Share by Region (2016-2021)
Table 6. Global Decitabine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Decitabine Revenue Share by Region (2016-2021)
Table 8. Global Decitabine Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Decitabine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Decitabine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Decitabine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Decitabine Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Decitabine Sales Share by Company (2016-2021)
Table 14. Global Decitabine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Decitabine Revenue Share by Company (2016-2021)
Table 16. Global Decitabine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decitabine as of 2020)
Table 17. Global Decitabine Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Decitabine Manufacturing Sites and Area Served
Table 19. Manufacturers Decitabine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Decitabine Sales (K Units) by Type (2016-2021)
Table 22. Global Decitabine Sales Share by Type (2016-2021)
Table 23. Global Decitabine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Decitabine Price (US$/Unit) by Type (2016-2021)
Table 25. Global Decitabine Sales Share by Type (2022-2027)
Table 26. Global Decitabine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Decitabine Revenue Share by Type (2022-2027)
Table 28. Global Decitabine Price (US$/Unit) by Type (2022-2027)
Table 29. Global Decitabine Sales (K Units) by Application (2016-2021)
Table 30. Global Decitabine Sales Share by Application (2016-2021)
Table 31. Global Decitabine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Decitabine Price (US$/Unit) by Application (2016-2021)
Table 33. Global Decitabine Sales (K Units) by Application (2022-2027)
Table 34. Global Decitabine Sales Share by Application (2022-2027)
Table 35. Global Decitabine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Decitabine Revenue Share by Application (2022-2027)
Table 37. Global Decitabine Price (US$/Unit) by Application (2022-2027)
Table 38. North America Decitabine Sales (K Units) by Company (2016-2021)
Table 39. North America Decitabine Sales Market Share by Company (2016-2021)
Table 40. North America Decitabine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Decitabine Revenue Market Share by Company (2016-2021)
Table 42. North America Decitabine Sales by Type (2016-2021) & (K Units)
Table 43. North America Decitabine Sales Market Share by Type (2016-2021)
Table 44. North America Decitabine Sales by Type (2022-2027) & (K Units)
Table 45. North America Decitabine Sales Market Share by Type (2022-2027)
Table 46. North America Decitabine Sales by Application (2016-2021) & (K Units)
Table 47. North America Decitabine Sales Market Share by Application (2016-2021)
Table 48. North America Decitabine Sales by Application (2022-2027) & (K Units)
Table 49. North America Decitabine Sales Market Share by Application (2022-2027)
Table 50. Europe Decitabine Sales (K Units) by Company (2016-2021)
Table 51. Europe Decitabine Sales Market Share by Company (2016-2021)
Table 52. Europe Decitabine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Decitabine Revenue Market Share by Company (2016-2021)
Table 54. Europe Decitabine Sales by Type (2016-2021) & (K Units)
Table 55. Europe Decitabine Sales Market Share by Type (2016-2021)
Table 56. Europe Decitabine Sales by Type (2022-2027) & (K Units)
Table 57. Europe Decitabine Sales Market Share by Type (2022-2027)
Table 58. Europe Decitabine Sales by Application (2016-2021) & (K Units)
Table 59. Europe Decitabine Sales Market Share by Application (2016-2021)
Table 60. Europe Decitabine Sales by Application (2022-2027) & (K Units)
Table 61. Europe Decitabine Sales Market Share by Application (2022-2027)
Table 62. China Decitabine Sales (K Units) by Company (2016-2021)
Table 63. China Decitabine Sales Market Share by Company (2016-2021)
Table 64. China Decitabine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Decitabine Revenue Market Share by Company (2016-2021)
Table 66. China Decitabine Sales by Type (2016-2021) & (K Units)
Table 67. China Decitabine Sales Market Share by Type (2016-2021)
Table 68. China Decitabine Sales by Type (2022-2027) & (K Units)
Table 69. China Decitabine Sales Market Share by Type (2022-2027)
Table 70. China Decitabine Sales by Application (2016-2021) & (K Units)
Table 71. China Decitabine Sales Market Share by Application (2016-2021)
Table 72. China Decitabine Sales by Application (2022-2027) & (K Units)
Table 73. China Decitabine Sales Market Share by Application (2022-2027)
Table 74. Japan Decitabine Sales (K Units) by Company (2016-2021)
Table 75. Japan Decitabine Sales Market Share by Company (2016-2021)
Table 76. Japan Decitabine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Decitabine Revenue Market Share by Company (2016-2021)
Table 78. Japan Decitabine Sales by Type (2016-2021) & (K Units)
Table 79. Japan Decitabine Sales Market Share by Type (2016-2021)
Table 80. Japan Decitabine Sales by Type (2022-2027) & (K Units)
Table 81. Japan Decitabine Sales Market Share by Type (2022-2027)
Table 82. Japan Decitabine Sales by Application (2016-2021) & (K Units)
Table 83. Japan Decitabine Sales Market Share by Application (2016-2021)
Table 84. Japan Decitabine Sales by Application (2022-2027) & (K Units)
Table 85. Japan Decitabine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Decitabine Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Decitabine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Decitabine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Decitabine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Decitabine Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Decitabine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Decitabine Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Decitabine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Decitabine Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Decitabine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Decitabine Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Decitabine Sales Market Share by Application (2022-2027)
Table 98. India Decitabine Sales (K Units) by Company (2016-2021)
Table 99. India Decitabine Sales Market Share by Company (2016-2021)
Table 100. India Decitabine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Decitabine Revenue Market Share by Company (2016-2021)
Table 102. India Decitabine Sales by Type (2016-2021) & (K Units)
Table 103. India Decitabine Sales Market Share by Type (2016-2021)
Table 104. India Decitabine Sales by Type (2022-2027) & (K Units)
Table 105. India Decitabine Sales Market Share by Type (2022-2027)
Table 106. India Decitabine Sales by Application (2016-2021) & (K Units)
Table 107. India Decitabine Sales Market Share by Application (2016-2021)
Table 108. India Decitabine Sales by Application (2022-2027) & (K Units)
Table 109. India Decitabine Sales Market Share by Application (2022-2027)
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Johnson & Johnson Decitabine Product
Table 114. Johnson & Johnson Recent Development
Table 115. Eli Lilly and Company Corporation Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Eli Lilly and Company Decitabine Product
Table 119. Eli Lilly and Company Recent Development
Table 120. Pharmachemie B.V. Corporation Information
Table 121. Pharmachemie B.V. Description and Business Overview
Table 122. Pharmachemie B.V. Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Pharmachemie B.V. Decitabine Product
Table 124. Pharmachemie B.V. Recent Development
Table 125. Otsuka Pharmaceutical Corporation Information
Table 126. Otsuka Pharmaceutical Description and Business Overview
Table 127. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Otsuka Pharmaceutical Decitabine Product
Table 129. Otsuka Pharmaceutical Recent Development
Table 130. Sandoz Corporation Information
Table 131. Sandoz Description and Business Overview
Table 132. Sandoz Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Sandoz Decitabine Product
Table 134. Sandoz Recent Development
Table 135. Dr Reddy's Laboratories Corporation Information
Table 136. Dr Reddy's Laboratories Description and Business Overview
Table 137. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Dr Reddy's Laboratories Decitabine Product
Table 139. Dr Reddy's Laboratories Recent Development
Table 140. Accord Healthcare Corporation Information
Table 141. Accord Healthcare Description and Business Overview
Table 142. Accord Healthcare Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Accord Healthcare Decitabine Product
Table 144. Accord Healthcare Recent Development
Table 145. Sun Pharmaceutical Corporation Information
Table 146. Sun Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Sun Pharmaceutical Description and Business Overview
Table 148. Sun Pharmaceutical Decitabine Product
Table 149. Sun Pharmaceutical Recent Development
Table 150. Cipla Corporation Information
Table 151. Cipla Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Cipla Description and Business Overview
Table 153. Cipla Decitabine Product
Table 154. Cipla Recent Development
Table 155. Lupin Corporation Information
Table 156. Lupin Description and Business Overview
Table 157. Lupin Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Lupin Decitabine Product
Table 159. Lupin Recent Development
Table 160. Shandong Xinshidai Pharmaceutical Corporation Information
Table 161. Shandong Xinshidai Pharmaceutical Description and Business Overview
Table 162. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Shandong Xinshidai Pharmaceutical Decitabine Product
Table 164. Shandong Xinshidai Pharmaceutical Recent Development
Table 165. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
Table 166. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 167. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product
Table 169. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development
Table 170. ZHENGDA Tianqing Pharmaceutical Group Corporation Information
Table 171. ZHENGDA Tianqing Pharmaceutical Group Description and Business Overview
Table 172. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product
Table 174. ZHENGDA Tianqing Pharmaceutical Group Recent Development
Table 175. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 176. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 177. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Jiangsu Aosaikang Pharmaceutical Decitabine Product
Table 179. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 180. Jiangsu Haosen Pharmaceutical Group Corporation Information
Table 181. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
Table 182. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 183. Jiangsu Haosen Pharmaceutical Group Decitabine Product
Table 184. Jiangsu Haosen Pharmaceutical Group Recent Development
Table 185. Lianyungang Jierui Pharmaceutical Corporation Information
Table 186. Lianyungang Jierui Pharmaceutical Description and Business Overview
Table 187. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 188. Lianyungang Jierui Pharmaceutical Decitabine Product
Table 189. Lianyungang Jierui Pharmaceutical Recent Development
Table 190. Qilu Pharmaceutical Hainan Corporation Information
Table 191. Qilu Pharmaceutical Hainan Description and Business Overview
Table 192. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 193. Qilu Pharmaceutical Hainan Decitabine Product
Table 194. Qilu Pharmaceutical Hainan Recent Development
Table 195. Lianyungang Runzhong Pharmaceutical Corporation Information
Table 196. Lianyungang Runzhong Pharmaceutical Description and Business Overview
Table 197. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 198. Lianyungang Runzhong Pharmaceutical Decitabine Product
Table 199. Lianyungang Runzhong Pharmaceutical Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Decitabine Distributors List
Table 203. Decitabine Customers List
Table 204. Decitabine Market Trends
Table 205. Decitabine Market Drivers
Table 206. Decitabine Market Challenges
Table 207. Decitabine Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Decitabine Product Picture
Figure 2. Global Decitabine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Decitabine Sales Market Share by Application in 2021 & 2027
Figure 6. Primary MDS Examples
Figure 7. Secondary MDS Examples
Figure 8. Global Decitabine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Decitabine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Decitabine Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Decitabine Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 12. Global Decitabine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Decitabine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Decitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Decitabine Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Decitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Decitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Decitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Decitabine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Decitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Decitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Decitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Decitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Decitabine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Decitabine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Decitabine Players Market Share by Revenue in Decitabine: 2016 & 2020
Figure 27. Decitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Decitabine Revenue Share by Type (2016-2021)
Figure 29. Global Decitabine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Decitabine Revenue Share by Application (2016-2021)
Figure 31. Global Decitabine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Decitabine Sales Market Share by Type in 2020
Figure 33. North America Decitabine Sales Market Share by Application in 2020
Figure 34. Europe Decitabine Sales Market Share by Type in 2020
Figure 35. Europe Decitabine Sales Market Share by Application in 2020
Figure 36. China Decitabine Sales Market Share by Type in 2020
Figure 37. China Decitabine Sales Market Share by Application in 2020
Figure 38. Japan Decitabine Sales Market Share by Type in 2020
Figure 39. Japan Decitabine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Decitabine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Decitabine Sales Market Share by Application in 2020
Figure 42. India Decitabine Sales Market Share by Type in 2020
Figure 43. India Decitabine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Decitabine
Figure 46. Manufacturing Process Analysis of Decitabine
Figure 47. Decitabine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’